Start

Bleeding Risk Index in Patients with Malignant Lymphoma or Solid Tumors

Purpose:

To identify a patient with malignant lymphoma or solid tumor who is likely to bleed following chemotherapy using the bleeding risk index of Elting et al.

Specialty:

Gynecological Oncology, Hematology/Oncology, Medical Oncology, Pediatric Hematology/Oncology

Objective:

risk factors, severity, prognosis, stage, complications

ICD-10:

C81, C82, C83, C85, D62

Description:

Elting et al developed a clinical prediction rule for identifying patients with malignant lymphoma or solid neoplasms who are at risk from hemorrhage associated with thrombocytopenia following chemotherapy. This can identify patients on day 1 of a chemotherapy cycle who are at risk for bleeding and may require platelet transfusion therapy. The authors are from M.D. Anderson Cancer Center in Houston.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone